Alio Raises $18M in First Close of Series C Financing
Posted:
Alio announces its latest round of funding. a medical technology company reinventing the management of chronic disease, announced it has raised $18 million in the initial close of a Series C financing, bringing the total amount the company has raised to over $50 million. Read more here.
Capital planning in healthcare is not merely an administrative obligation—it is a strategic discipline that shapes clinical capabilities, operational resilience and financial health.
Recognising and addressing common planning mistakes is essential to sustaining high-quality, efficient care in an increasingly complex…
The US Food and Drug Administration has approved the first eye drop that could allow users to ditch their bifocals—or at least rely on them far less often. Developed by the pharmaceutical company LENZ, VIZZ is an aceclidine ophthalmic treatment in the form of…
Attendees
Sponsors and Exhibitors
Contact us